These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2503604)

  • 1. Transdermal delivery of levonorgestrel. IV: Evaluation of membranes.
    Friend DR; Catz P; Heller J; Okagaki M
    J Pharm Sci; 1989 Jun; 78(6):477-80. PubMed ID: 2503604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro.
    Friend DR; Catz P; Heller J; Okagaki M
    Pharm Res; 1989 Nov; 6(11):938-44. PubMed ID: 2512569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluations of transdermal levonorgestrel.
    Catz P; Friend DR
    Drug Des Deliv; 1990 May; 6(1):49-60. PubMed ID: 2127673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of levonorgestrel.
    Friend DR
    Med Res Rev; 1991 Jan; 11(1):49-80. PubMed ID: 1899713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of levonorgestrel. VII. In vivo studies.
    Friend DR; Catz P; Phillips S
    Contraception; 1989 Jul; 40(1):73-80. PubMed ID: 2505971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of vehicles on human skin permeation of norgestrel and levonorgestrel in vitro].
    Zhong JP; Zhou RR; Chen GS; Wang Y; Wang JG
    Yao Xue Xue Bao; 1991; 26(12):933-7. PubMed ID: 1823994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis.
    Rastogi SK; Singh J
    Pharm Res; 2002 Apr; 19(4):427-33. PubMed ID: 12033375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvone on the permeation of nimodipine from a membrane-moderated transdermal therapeutic system.
    Krishnaiah YS; Bhaskar P; Satyanarayana V
    Pharmazie; 2003 Aug; 58(8):559-63. PubMed ID: 12967033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous effects of transdermal levonorgestrel.
    Friend DR; Phillips SJ; Hill JR
    Food Chem Toxicol; 1991 Sep; 29(9):639-46. PubMed ID: 1937296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of interaction between levonorgestrel and ethanol.
    Gomaa AA; Osman FH; Salem HT; Abdel Wareth AA
    Contraception; 1984 Jun; 29(6):535-42. PubMed ID: 6432432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
    Cho CW; Choi JS; Yang KH; Shin SC
    Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of fertility by means of vaginal rings medicated with estradiol and levonorgestrel].
    Díaz S; Croxatto HB; Pavez M; Miranda P; Sivin I
    Rev Chil Obstet Ginecol; 1982; 47(4):266-73. PubMed ID: 6821442
    [No Abstract]   [Full Text] [Related]  

  • 17. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
    Krishnaiah YS; Bhaskar P; Satyanarayana V
    Drug Deliv; 2004; 11(1):1-9. PubMed ID: 15168785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral contraception, 1986. Currently available formulations.
    Hale R
    J Reprod Med; 1986 Jun; 31(6 Suppl):557-8. PubMed ID: 3088272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous absorption enhancer applied to membrane permeation-controlled transdermal delivery of nicardipine hydrochloride.
    Seki T; Sugibayashi K; Juni K; Morimoto Y
    Drug Des Deliv; 1989 Jan; 4(1):69-75. PubMed ID: 2775447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.